scholarly article | Q13442814 |
P356 | DOI | 10.1097/00007890-199601270-00015 |
P698 | PubMed publication ID | 8600632 |
P2093 | author name string | K Tanaka | |
N Ozaki | |||
H Egawa | |||
T Hashida | |||
Y Yamaoka | |||
Y Inomata | |||
T Kiuchi | |||
K Satomura | |||
S Uemoto | |||
H Okajima | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 247-252 | |
P577 | publication date | 1996-01-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation | |
P478 | volume | 61 |
Q47329951 | A nomogram for predicting the optimal oral dosage of tacrolimus in liver transplant recipients with small-for-size grafts |
Q73932596 | Advances in the development of immunosuppressive agents in organ transplantation |
Q43584355 | Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance |
Q77583304 | Biliary complications in pediatric living related liver transplantation |
Q50114384 | Biliary reconstruction in right lobe living-donor liver transplantation: Comparison of different techniques in 321 recipients |
Q73322566 | Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications1,2 |
Q77067731 | Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation |
Q34332261 | Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation |
Q47223579 | Correlation between graft size and necessary tacrolimus dose after living-related liver transplantation |
Q73278354 | Effectiveness of 15-deoxyspergualin on steroid-resistant acute rejection in living related liver transplantation |
Q44912010 | Effects of post-transplant enteral nutrition with an immunomodulating diet containing hydrolyzed whey peptide after liver transplantation |
Q57106909 | Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation |
Q51503491 | Exposure of hepatic sinusoidal mononuclear cells to UW solution in situ but not ex vivo induces apoptosis. |
Q40552763 | Forecasting of Blood Tacrolimus Concentrations Based on the Bayesian Method in Adult Patients Receiving Living-Donor Liver Transplantation |
Q39001834 | Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis |
Q91850730 | Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation |
Q43476264 | Impact of the development of a liver transplant program on the treatment of biliary atresia in an institution in Japan |
Q89057724 | Liver Transplantation for Intermediate-Stage Hepatocellular Carcinoma |
Q53807979 | Liver transplantation for advanced hepatocellular carcinoma in patients with Child-Pugh A and B. |
Q37360177 | Liver transplantation for small hepatocellular carcinoma |
Q72991926 | Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease |
Q35422169 | Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study |
Q46048992 | Long-term results of pediatric liver transplantation: an analysis of 569 transplants |
Q60932740 | Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study |
Q47361181 | Lower limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver transplantation in combination with portal pressure control. |
Q74219332 | Lymphoproliferative disorders in patients undergoing living-related liver transplantation |
Q77632858 | Neoral-based immunosuppression in living-related donor liver transplantation |
Q38796186 | New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function. |
Q79633266 | Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases |
Q74579834 | Pediatric liver transplantation with cadaveric or living related donors: comparative results in 90 elective recipients of primary grafts |
Q52230151 | Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients. |
Q36055374 | Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients |
Q74219327 | Posttransplant hepatitis B infection in liver transplantation with hepatitis B core antibody-positive donors |
Q83675820 | Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence? |
Q80335933 | Remaining caudate lobe in the right lobe graft in living donor liver transplantation: a blind spot? |
Q78256916 | Severe late acute allograft rejection in a child after living-related auxiliary partial orthotopic liver transplantation for ornithine transcarbamylase deficiency |
Q40584058 | Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation |
Q43298558 | Surgical complications after living donor liver transplantation in patients with biliary atresia: a relatively high incidence of portal vein complications |
Q44230295 | Tacrolimus in pediatric liver transplantation |
Q28258318 | Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation |
Q73578526 | Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation |
Q89036819 | The Impact of Preoperative Hemoglobin Level on the Short-Term Outcomes After Living Donor Liver Transplantation |
Q74686089 | The necessity for steroid induction or long-term maintenance after liver transplantation: the argument against |
Q77736673 | Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in a living-donor program |
Search more.